Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and mutation
A late preterm infant had pulmonary hypertension caused by a variety of mechanisms leading to complex management. This child had complete atrioventricular septal defect associated with mild left ventricular hypoplasia and Down syndrome diagnosed prenatally. The mother had been treated by antiretrovi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-07-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/20458940211027433 |
id |
doaj-8b2cf3c81cee4ac1be1c8134f1a18e28 |
---|---|
record_format |
Article |
spelling |
doaj-8b2cf3c81cee4ac1be1c8134f1a18e282021-07-06T22:03:42ZengSAGE PublishingPulmonary Circulation2045-89402021-07-011110.1177/20458940211027433Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and mutationFanny BajolleS. Malekzadeh-MilaniM. LévyD. BonnetA late preterm infant had pulmonary hypertension caused by a variety of mechanisms leading to complex management. This child had complete atrioventricular septal defect associated with mild left ventricular hypoplasia and Down syndrome diagnosed prenatally. The mother had been treated by antiretroviral HIV treatment during pregnancy. Aortic coarctation was diagnosed and rapidly repaired. After surgery, he required noninvasive ventilation for persisting elevated PCO 2 . Pulmonary CT scan showed normal bronchial tree, lung parenchymal abnormalities with mosaic aspect and hyperlucent zones, and indirect signs of lung hypoplasia with peripheral microbubbles. During follow-up, severe pulmonary hypertension was diagnosed on echocardiography without recoarctation, significant intracardiac shunting or diastolic dysfunction. The patient died after four months unable to be weaned from noninvasive ventilation. Post mortem lung biopsy showed abnormally muscularized arterioles with intimal fibrosis and pulmonary immaturity. Gentetic screening identified a BMPR-2 mutation. This patient illustrates the multifactorial origin of pulmonary hypertension in the neonatal period. The respective contribution of left-to-right shunt, post-capillary obstruction, and abnormally elevated pulmonary vascular resistances led to perform right heart catheterization to exclude excessive shunting and restrictive physiology of the left heart. Subjects with Down syndrome are also highly susceptible to decreased lung vascular and alveolar growth, which may increase the risk for pulmonary hypertension and lung hypoplasia. This case highlights two issues. The first one is that right heart catheterization should be discussed in neonates with unexplained pulmonary hypertension and the second is to extend indications of genetic testing for pulmonary hypertension genes in neonates who have unusual course of neonatal pulmonary hypertension, particularly in the setting of associated congenital heart disease (CHD).https://doi.org/10.1177/20458940211027433 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fanny Bajolle S. Malekzadeh-Milani M. Lévy D. Bonnet |
spellingShingle |
Fanny Bajolle S. Malekzadeh-Milani M. Lévy D. Bonnet Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and mutation Pulmonary Circulation |
author_facet |
Fanny Bajolle S. Malekzadeh-Milani M. Lévy D. Bonnet |
author_sort |
Fanny Bajolle |
title |
Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and mutation |
title_short |
Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and mutation |
title_full |
Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and mutation |
title_fullStr |
Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and mutation |
title_full_unstemmed |
Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and mutation |
title_sort |
multifactorial origin of pulmonary hypertension in a child with congenital heart disease, down syndrome, and mutation |
publisher |
SAGE Publishing |
series |
Pulmonary Circulation |
issn |
2045-8940 |
publishDate |
2021-07-01 |
description |
A late preterm infant had pulmonary hypertension caused by a variety of mechanisms leading to complex management. This child had complete atrioventricular septal defect associated with mild left ventricular hypoplasia and Down syndrome diagnosed prenatally. The mother had been treated by antiretroviral HIV treatment during pregnancy. Aortic coarctation was diagnosed and rapidly repaired. After surgery, he required noninvasive ventilation for persisting elevated PCO 2 . Pulmonary CT scan showed normal bronchial tree, lung parenchymal abnormalities with mosaic aspect and hyperlucent zones, and indirect signs of lung hypoplasia with peripheral microbubbles. During follow-up, severe pulmonary hypertension was diagnosed on echocardiography without recoarctation, significant intracardiac shunting or diastolic dysfunction. The patient died after four months unable to be weaned from noninvasive ventilation. Post mortem lung biopsy showed abnormally muscularized arterioles with intimal fibrosis and pulmonary immaturity. Gentetic screening identified a BMPR-2 mutation. This patient illustrates the multifactorial origin of pulmonary hypertension in the neonatal period. The respective contribution of left-to-right shunt, post-capillary obstruction, and abnormally elevated pulmonary vascular resistances led to perform right heart catheterization to exclude excessive shunting and restrictive physiology of the left heart. Subjects with Down syndrome are also highly susceptible to decreased lung vascular and alveolar growth, which may increase the risk for pulmonary hypertension and lung hypoplasia. This case highlights two issues. The first one is that right heart catheterization should be discussed in neonates with unexplained pulmonary hypertension and the second is to extend indications of genetic testing for pulmonary hypertension genes in neonates who have unusual course of neonatal pulmonary hypertension, particularly in the setting of associated congenital heart disease (CHD). |
url |
https://doi.org/10.1177/20458940211027433 |
work_keys_str_mv |
AT fannybajolle multifactorialoriginofpulmonaryhypertensioninachildwithcongenitalheartdiseasedownsyndromeandmutation AT smalekzadehmilani multifactorialoriginofpulmonaryhypertensioninachildwithcongenitalheartdiseasedownsyndromeandmutation AT mlevy multifactorialoriginofpulmonaryhypertensioninachildwithcongenitalheartdiseasedownsyndromeandmutation AT dbonnet multifactorialoriginofpulmonaryhypertensioninachildwithcongenitalheartdiseasedownsyndromeandmutation |
_version_ |
1721317103263285248 |